Rekvina Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Rekvina Laboratories Ltd. on BSE

Load latest

Rekvina Laboratories Ltd.

20 Jan 2025

Board Meeting

REKVINA LABORATORIES LTD. - 526075 - Board Meeting Outcome for Board Meeting Outcome For Board Meeting …

BSE India

Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 20th January, 2025 has inter-alia adopted and approved 1)The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2024.

pdf

Rekvina Laboratories Ltd.

20 Jan 2025

Company Update

REKVINA LABORATORIES LTD. - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

pdf

Rekvina Laboratories Ltd.

13 Jan 2025

Board Meeting

REKVINA LABORATORIES LTD. - 526075 - Board Meeting Intimation for Board Meeting To Be Held On …

BSE India

REKVINA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on 20th January, 2025, inter alia; 1. To consider and approve Un-audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter ended on 31st December, 2024. 2. Any other agendas as may be considered necessary with the permission of the chair.

pdf

Rekvina Laboratories Ltd.

08 Jan 2025

Company Update

REKVINA LABORATORIES LTD. - 526075 - Reply With Respect To Reason For Delay Submission Of Information …

BSE India

please find attached herewith reply.

pdf

Rekvina Laboratories Ltd.

30 Dec 2024, 06:21PM

SAST

REKVINA LABORATORIES LTD. - 526075 - Closure of Trading Window

BSE India

Closure of Trading Window for the Quarter Ended on 31st December ,2024.

pdf

Rekvina Laboratories Ltd.

04 Dec 2024

Company Update

REKVINA LABORATORIES LTD. - 526075 - Appointment of Company Secretary and Compliance Officer

BSE India

Appointment of Mr. Deepak Khandelwal (A31480) as a Company Secretary and Compliance Officer of the company.

pdf

Rekvina Laboratories Ltd.

14 Nov 2024

Company Update

REKVINA LABORATORIES LTD. - 526075 - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure …

BSE India

Non-Applicability of Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulation, 2018 for half year ended on 30.09.2024

pdf

Rekvina Laboratories Ltd.

14 Nov 2024

Result

REKVINA LABORATORIES LTD. - 526075 - Financial Result For Quarter And Half Year Ended On 30Th …

BSE India

Financial Result for quarter and half year ended on 30th September 2024.

pdf

Rekvina Laboratories Ltd.

14 Nov 2024

Board Meeting

REKVINA LABORATORIES LTD. - 526075 - Board Meeting Outcome for Board Meeting Held On 14Th November …

BSE India

Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 14th November, 2024 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2024.

pdf

Rekvina Laboratories Ltd.

08 Nov 2024

Board Meeting

REKVINA LABORATORIES LTD. - 526075 - Board Meeting Intimation for Board Meeting To Be Held On …

BSE India

REKVINA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Un-audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Half Year ended on 30th September, 2024 and any other agendas as may be considered necessary with the permission of the chair.

pdf

Is Rekvina Laboratories Ltd. worth buying?

8 Votes:

Buy 75.0%

Hold 25.0%